Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00581815 · ClinicalTrials.gov registry record · Phase 1
Spectroscopy With Surface Coils and Decoupling
A Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 582
- Enrollment target
NCT00581815: Completed Phase 1 study, sponsored by Memorial Sloan Kettering Cancer Center.
NCT00581815 is a Phase 1 study that has completed, run by Memorial Sloan Kettering Cancer Center. The registered enrollment target is 582 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00581815, a Phase 1 study, has completed, sponsored by Memorial Sloan Kettering Cancer Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 582 participants
- Enrollment target
Study Summary
The purpose of this study is to obtain chemical information from part of your body without a biopsy. This is done using a technique called magnetic resonance spectroscopy (MRS) which is similar to magnetic resonance imaging (MRI) except that signals are detected from the chemicals (spectroscopy) naturally present in your body using radio waves. To receive this information from your body, small loops of wire (surface coils), placed near the tissue of interest, may be used to more effectively detect signals that come from the chemicals in your body. The investigators may use a second radio channel simultaneously, which will allow us to obtain greater chemical information (decoupling). The results may also help us to understand how this study can be used to help other patients with your condition.
Interventions
- DEVICE Proton-decoupled 31P MRS at 1.5T
- DEVICE 1H Spectroscopy at 1.5T and 3T
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 582 participants |
| Start Date | 1997-02 |
| Est. Completion | 2014-02 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00581815
The ClinicalTrials.gov registry entry for NCT00581815 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 582 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Memorial Sloan Kettering Cancer Center, which has 1,884 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Proton-decoupled 31P MRS at 1.5T is the first listed.
NCT00581815 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00581815 about?
NCT00581815 is a clinical study titled "Spectroscopy With Surface Coils and Decoupling". The purpose of this study is to obtain chemical information from part of your body without a biopsy. This is done using a technique called magnetic resonance spectroscopy (MRS) which is similar to magnetic resonance imaging (MRI) except that signals are detected from the chemicals (spectroscopy) nat...
What is the current status of trial NCT00581815?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 582 participants. The study started on 1997-02. Estimated completion is 2014-02.
What interventions are being tested in trial NCT00581815?
The interventions under investigation include: Proton-decoupled 31P MRS at 1.5T (DEVICE), 1H Spectroscopy at 1.5T and 3T (DEVICE).
Who is sponsoring clinical trial NCT00581815?
This trial is sponsored by Memorial Sloan Kettering Cancer Center, which has 1,884 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.